One Day Closer showcases how researchers and clinicians at the Rogel Cancer Center are getting us one day closer to a cure for cancer. Area high school students and their families are invited to learn about cancer research through interactive activities and booths, short research talks, and lab tours. We hope this event will inspire the next generation of scientists and clinicians, so we can ensure a strong future in our fight against cancer!
University of Michigan School of Nursing professor and Rogel Cancer Center member, Christopher Friese has been appointed a member of the Governing Board of the Patient-Centered Outcomes Research Institution, part of the US Government Accountability Office.
The University of Michigan School of Public Health will house a new, multi-institutional center focusing on modeling and predicting the impact of tobacco regulation, funded with an $18 million federal grant from the National Institutes of Health and the Food and Drug Administration.
Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.
New research by Max Wicha, M.D., director of the Forbes Institute for Cancer Discovery, helps explain why stem cells become resistant to cancer treatment and opens a clever new way to go after them
MENU
